160785-77-3

Upstream product

• 957-68-6 7-Aminocephalosporanic acid 
• 27267-35-2 7-formylamino-3-acetoxymethyl-3-cephem-4-carboxylic acid 
• 406-34-8 2-fluoroethylamine 
• 530-62-1 1,1'-carbonyldiimidazole 
• 49599-37-3 diphenylmethyl 7-formamido-3-hydroxymethyl-Δ³-cephem-4-carboxylate 

Downstream Products

• 142967-09-7 (6R,7R)-3-(2-Fluoro-ethylcarbamoyloxymethyl)-8-oxo-7-{2-[2-(trityl-amino)-thiazol-4-yl]-2-[(Z)-trityloxyimino]-acetylamino}-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 160785-95-5 (6R,7R)-7-Amino-3-(2-fluoro-ethylcarbamoyloxymethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 160785-82-0 (6R,7R)-3-(2-Fluoro-ethylcarbamoyloxymethyl)-7-formylamino-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 

Relevant academic research and scientific papers

Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins

The synthesis and antibacterial activities of 7β-[2-(-aminothiazol-4-yl)-2-hydroxyiminoacetami-do]-3-N,N -dimethylcarbamoyloxymethyl-3-cephem-4-carboxylic acid (E1100) and its analogs are described, as well as oral absorbability and in vivo activities of